GE HealthCare Technologies Inc. (GEHC) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Healthcare Information Services secteur d'activité. Le siège social de l'entreprise est situé à Chicago, IL, United States. Le PDG actuel est Peter J. Arduini.
GEHC a date d'introduction en bourse 2022-12-15, 53,000 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $34.07B.
GE HealthCare Technologies Inc. is a global medical technology company headquartered in Chicago, Illinois, that develops, manufactures, and markets diagnostic imaging systems, patient monitoring solutions, and pharmaceutical contrast agents. Operating through four segments—Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics—the company serves healthcare providers across the United States, Europe, Asia, Africa, and the Middle East. Its Imaging segment offers CT, MR, X-ray, and molecular imaging systems, while its Ultrasound segment provides ultrasound solutions for radiology, cardiology, and point-of-care applications. The Patient Care Solutions segment delivers patient monitoring, anesthesia, respiratory care, and maternal infant care products and services, whereas the Pharmaceutical Diagnostics segment supplies contrast media and radiopharmaceuticals essential for diagnostic imaging procedures. Through its comprehensive portfolio of hardware, software, and digital solutions, GE HealthCare enables clinicians to diagnose, treat, and monitor patients more effectively.
